InsiderTrades

Form 4 for PRVA Privia Health Group, Inc.

Accepted 2022-09-08 00:00:00 ET · period of report 2022-09-06 · accession 0001759655-22-000126 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-09-08 2022-09-06 PRVA Mountcastle David EVP, CFO S - Sale+OE $40.14 -6,159 159.2K -4% -$247.2K
D 2022-09-08 2022-09-06 PRVA Mountcastle David EVP, CFO M - OptEx $2.00 +12.9K 165.4K +8% +$25.7K
D 2022-09-08 2022-09-06 PRVA Mountcastle David EVP, CFO M - OptEx $0.00 -12.9K 51.0K -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.01 per share 2022-09-06 S D 6,159 $40.14 159,195 D — —
2 Common Common Stock, par value $0.01 per share 2022-09-06 M A 12,862 $2.00 165,354 D — —
3 Derivative Stock Option (Right to Purchase) 2022-09-06 M D 12,862 $0.00 51,037 D $2.00 · — to 2028-08-27 12,862 Common Stock (F2) Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transaction reported in this Form 4, 38,380 of the stock options are fully vested and exercisable. 25,519 will vest on October 29, 2022.